Barren promise : the hope and heartache in treating infertility
Name
65192688-MIT.pdf
Description
Full printable version
Size
1.84 MB
Format
Adobe PDF
Checksum (MD5)
24f666c14addab0a983058b000569a49
Author(s)
McDonough, Maureen (Maureen Ann)
Advisor(s)
Marcia Bartusiak.
Alternative Title
Hope and heartache in treating infertility
Date Issued
2005
Publisher
Massachusetts Institute of Technology
Abstract
Preimplantation Genetic Diagnosis (PGD) is a reproductive medicine technology that allows the genetic characteristics of embryos to be examined. Created through in vitro fertilization, embryos are grown in a Petri dish for three days, at which point they have eight cells. One cell is then removed from each embryo and tested for certain genetic characteristics. Based on the results, selected embryos are transferred into a woman's uterus. Originally developed as a way to screen embryos for genetic disorders, PGD was used among a limited number of patients. More recently, however, some physicians and researchers have deemed PGD a useful infertility treatment. As a result, the number of people using PGD has increased every year since the technology was first developed in 1989. The role of PCGD as an emerging infertility treatment was examined from research, clinical, and personal perspectives. This was done through literature searches, interviews, laboratory observations, and attendance at infertility support meetings.
Description
Thesis (S.M.)--Massachusetts Institute of Technology, Dept. of Humanities, Program in Writing and Humanistic Studies, 2005.
Includes bibliographical references (leaf 38).
Subjects
Program in Writing and Humanistic Studies.
MIT Department
MIT Program in Writing & Humanistic Studies
Terms of Use
M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.
Persistent DSpace Link
